Predicting Gleason Group progression for men on prostate cancer active surveillance: The role of a negative confirmatory MRI-US fusion biopsy
The Journal of Urology Aug 01, 2018
Bloom JB, et al. - In men with prostate cancer, authors ascertained the prognostic implications of negative multi-parametric magnetic resonance imaging (mpMRI)-transrectal ultrasound (TRUS) guided fusion biopsy (FB) involving extended sextant, systematic biopsy (SB) plus mpMRI-guided targeted biopsy of suspicious MRI lesions. A favorable prognosis for Gleason Grade Group progression was conferred by a negative confirmatory FB. While counseling patients about the risk of progression and planning future follow-up and biopsies for patients on active surveillance, these results could be used.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries